NORTHWEST BIOTHERAPEUTICS INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements
NORTHWEST BIOTHERAPEUTICS INC (NWBO) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements of $500.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation › Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Purchases, (Sales), Issuances, (Settlements)
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements · last filed 2026-08-14
- NORTHWEST BIOTHERAPEUTICS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2026-06-30 was $0.00.
- NORTHWEST BIOTHERAPEUTICS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2026-03-31 was $500.00K, a 4.76% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- NORTHWEST BIOTHERAPEUTICS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for the quarter ending 2025-09-30 was $475.00K.
- NORTHWEST BIOTHERAPEUTICS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2025 was $1.00M, a 9.91% decline from fiscal 2024.
- NORTHWEST BIOTHERAPEUTICS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2024 was $1.11M.
- NORTHWEST BIOTHERAPEUTICS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2019 was $6.60M.
- NORTHWEST BIOTHERAPEUTICS INC fair value, measurement with unobservable inputs reconciliation, recurring basis, liability, settlements for fiscal 2017 was $3.05M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $500.00K 10-Q · filed 2026-08-14 | $500.00K derived: sum of 3 quarters · filed 2026-08-14 | $975.00K derived: sum of 4 quarters · filed 2026-08-14 | |
| 2026-03-31 | $500.00K 10-Q · filed 2026-05-15 | $500.00K derived: sum of 2 quarters · filed 2026-05-15 | $975.00K derived: sum of 3 quarters · filed 2026-05-15 | $975.00K derived: sum of 4 quarters · filed 2026-05-15 | |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $475.00K derived: sum of 2 quarters · filed 2026-04-15 | $475.00K derived: sum of 3 quarters · filed 2026-04-15 | $1.00M 10-K · filed 2026-04-15 | |
| 2025-09-30 | $475.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $475.00K derived: sum of 2 quarters · filed 2025-11-14 | $1.00M 10-Q · filed 2025-11-14 | $1.31M derived: sum of 4 quarters · filed 2026-04-15 | |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | $525.00K 10-Q · filed 2025-08-14 | $835.00K derived: sum of 3 quarters · filed 2026-04-15 | ||
| 2025-03-31 | $525.00K 10-Q · filed 2025-05-15 | $835.00K derived: sum of 2 quarters · filed 2026-04-15 | |||
| 2024-12-31 | $310.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-15 | $1.11M 10-K · filed 2026-04-15 | |||
| 2024-09-30 | $800.00K 10-Q · filed 2024-11-12 | ||||
| 2019-12-31 | $6.60M 10-K · filed 2021-03-31 | ||||
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02 | $3.05M 10-K · filed 2019-04-02 | -$3.05M 10-K · filed 2018-04-17 | ||
| 2017-09-30 | $3.05M 10-Q · filed 2017-11-20 | ||||
| 2015-12-31 | $299.00K 10-K · filed 2017-04-17 |